DIFFERENTIAL ADENOASSOCIATED VIRUS VECTOR-DRIVEN EXPRESSION OF A NEUROPEPTIDE-Y GENE IN PRIMARY RAT-BRAIN ASTROGLIAL CULTURES AFTER TRANSFECTION WITH SENDAI VIROSOMES VERSUS LIPOFECTIN(TM)
Cm. Defiebre et al., DIFFERENTIAL ADENOASSOCIATED VIRUS VECTOR-DRIVEN EXPRESSION OF A NEUROPEPTIDE-Y GENE IN PRIMARY RAT-BRAIN ASTROGLIAL CULTURES AFTER TRANSFECTION WITH SENDAI VIROSOMES VERSUS LIPOFECTIN(TM), Neurochemical research, 19(6), 1994, pp. 643-648
The ability of Sendai virosomes or Lipofectin(TM) to introduce an AAV
vector into primary rat brain astroglial cultures was characterized. T
he pJDT95npy vector was constructed by inserting rat NPY cDNA downstre
am from the indigenous AAV p5, p19 and p40 promoters in pJDT95. Lipofe
ctin(TM)-mediated transfection with pJDT95npy (10 mu g) resulted in pr
onounced expression of several NPY mRNA species: p5-driven (3.3 kb), p
19-driven (2.7 kb) and p40-driven (0.6, 0.8, 1.1, and 1.8 kb). Exposur
e to virosomally encapsulated pJDT95npy (50 or 100 ng) resulted in tra
nsient expression of some p40-driven mRNA species (0.8 and 1.8 kb). Ne
ither method produced astroglia cells which synthesized mature NPY imm
unoreactivity. This demonstrates that an AAV-derived vector can drive
gene expression in astroglia, that Sendai virosomes can infuse vectors
into astroglia, but that the amount of DNA infused in this manner may
limit long term expression.